NEW YORK, Feb. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Monoclonal Antibody Based Products - Global Trends
http://www.reportlinker.com/p0164349/Monoclonal-Antibody-Based-Products---Global-Trends.html
Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. Monoclonal Antibody (MAb)-based products market is one of the fastest growing categories of the biopharmaceuticals industry. These products are of high significance for pharmaceutical industry, both in research as well as drug development activities. MAbs function as production repositories for developing drugs, and are used in the manufacture of highly specialized diagnostic products. Rapid technological advancements that enable antibodies to specifically target disease-causing cells are expected to boost prospects in the global therapeutic and diagnostic monoclonal antibodies market.
These and other market data and trends are presented in "Monoclonal Antibody-Based Products: Global Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
MONOCLONAL ANTIBODY BASED PRODUCTS BMR-1149
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4
MAb Market - Set for Significant Growth 4
Therapeutic mAb Market - Principal Driving Force 5
Development of New MAbs on a Fast Track 6
Genomics Research Leads Way to New Monoclonal Antibodies 6
Bright Outlook for Mabs 7
Current and Future Analysis 7
Product Segment Perspective 7
Competitive Scenario 7
Intensifying Consolidation Activity 8
Drug Developers Trying to Break the Shackles 11
Rituximab Vs. Epratuzumab 11
A Revolution Not too Far 11
Milestones in Development of MAbs 11
Focus on Unmet Medical Needs in the Emerging Markets 12
3. TRENDS AND ISSUES 12
Shift Towards Humanized and Fully Human Antibodies 12
Ageing Baby Boomers Spur MAbs Growth 12
Non-Existent Generic Competition Favors MAb Market 13
Partnerships and Collaborations Spark Increase in Profit Margins 13
Pharma Majors & CMOs Augment Investment in Mab Production 13
Rising Number of MAbs Under Clinical Trials 14
Select Clinical Trials for Monoclonal Antibodies 14
Major Monoclonal Antibodies in Phase III Trials Across the World 15
High Costs Impede MAbs Penetration 16
Opportunities in Technology Development 16
Advancements & Challenges in Antibody Production Processes 17
Increasing Demand for Protein A in Mab Manufacturing 17
FCA- A Major Cause for Discomfort in Mice 17
Innovations to Drive Growth in Anti-Ovarian Cancer Drugs Market 18
Rising Incidence of NHL to Drive Monoclonal Antibody Drug Market 18
4. PRODUCT FACTS 19
A.Therapeutics 19
Cancer 19
Other Therapeutic Mabs 20
B.Diagnostics 20
Types of Monoclonal Antibodies 20
5. CORPORATE DEVELOPMENTS 21
Callisto Merger Corporation Merges with Celldex Therapeutics 21
SDI to Develop mAbs for SAIC-F and NCI 21
HGS Reacquires Rights for TRAIL Receptor Antibodies 22
Amgen Enters into Licensing Agreement with Kyowa Hakko 22
Dyax and Sanofi-Aventis Sign Agreements 22
HGS Enters into Antibody Collaboration Agreement with Xencor 23
Amgen Introduces Vectibix 23
UCB Receives FDA Approval for Cimzia® 23
Genentech Acquires Tanox 23
Biotest Acquires Assets of Nabi Biologics 24
CMC Acquires ICOS Biologics Operation 24
Roche Takes Over THP 24
GTC and LFB Commence CD20 Monoclonal Antibody Development 25
Amgen Inks Collaboration and License Pact with Daiichi Sankyo 25
CMC Biopharmaceuticals Inks Agreement with Morphotek 26
CMC Biopharmaceuticals Inks Agreement with Biotest 26
Eli Lilly Collaborates with MacroGenics 26
Genentech Inks Global Licensing Agreement with Seattle Genetics 27
6. MAJOR PLAYERS 27
Amgen, Inc. (US) 27
BD Biosciences (US) 27
Biogen Idec Inc (US) 27
Biotest AG (Germany) 28
CMC ICOS Biologics, Inc. 28
Dendreon Corporation (US) 28
Elan Corporations Plc (Ireland) 28
Eli Lilly and Company (US) 28
Genentech, Inc. (US) 29
Human Genome Sciences, Inc. (US) 29
Immunomedics, Inc. (US) 29
Johnson & Johnson (US) 29
Centocor (US) 29
Ortho Biotech Products, L.P. (US) 30
Medarex, Inc. (US) 30
MedImmune, Inc. (US) 30
PDL BioPharma (US) 30
Schering-Plough Corporation (US) 31
Strategic Diagnostics Inc (US) 31
UCB Group (Belgium) 31
Wyeth Pharmaceuticals (US) 31
7. MARKET ANALYTICS 32
8. THE UNITED STATES 38
Therapeutic Monoclonal Antibodies Market - An Overview 38
New Heights for US Cancer Therapeutics 38
Competitive Landscape 39
Leading Products 39
9. CANADA 41
10. JAPAN 42
11. EUROPE 43
a. France 48
b. Germany 49
c. Italy 50
d. The United Kingdom 51
e. Rest of Europe 53
12. REST OF WORLD 54
Australia 54
Australia is All Set to Meet the Increasing Demand 54
India 54
EXHIBITS
Table 1: Major Acquisitions of Antibody-Focused Companies -
2007
Table 2: Market Shares of Leading Players in the Global
Monoclonal Antibody Therapy Market - 2005
Table 3: Market Shares of Leading Drugs in the Global
Therapeutic Monoclonal Antibodies Market - 2006
Table 4: Market Shares of Leading Antibody Based Products
Manufacturers in the World - 2004
Table 5: Market Shares of Leading Drugs in the Global
Monoclonal Antibody Based Products Market - 2004
Table 6: Market Shares of Leading Oncology Monoclonal
Antibodies Products in the World - 2008E
Table 7: Market Shares of Leading Antibody-Based
Anti-Inflammatory Products in the World - 2006
Table 8: Global Mab Market by Product Type - 2008
Table 9: Market Shares of Monoclonal Antibody Therapies in the
World - 2010E
Table 10: Global Market for Monoclonal Antibody Based Products
by Region for the Period 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Global Market for Monoclonal
Antibody Based Products by Region for the Years 2008 & 2012
Table 12: Global Therapeutics Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Global Therapeutics Market
by Region for the Years 2008 & 2012
Table 14: Global Therapeutic Monoclonal Antibody Based
Products Market by Segments for the Period 2007- 2015 (Sales
in US$ Million)
Table 15: Percentage Breakdown of Global Therapeutic
Monoclonal Antibody Based Products Market by Segments for the
Years 2008 & 2012
Table 16: Global Cancer Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Global Cancer Market by
Region for the Years 2008 & 2012
Table 18: Global Other Therapeutic Monoclonal Antibody Based
Products Market by Region for the Period 2007-2015 (Sales in
US$ Million)
Table 19: Percentage Breakdown of Global Other Therapeutic
Monoclonal Antibody Based Products Market by Region for the
Years 2008 & 2012
Table 20: Global Diagnostics Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown of Global Diagnostics Market by
Region for the Years 2008 & 2012
Table 22: Market Shares of Leading Therapeutic Monoclonal
Antibodies Products in the US - 2007
Table 23: Market Shares of Leading Therapeutic Monoclonal
Antibodies Products Manufacturers in the US - 2007
Table 24: Monoclonal Antibody Based Products Market by Segment
in the US: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in the US for the Years 2008 & 2012
Table 26: Monoclonal Antibody Based Products Market by Segment
in Canada: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Canada for the Years 2008 & 2012
Table 28: Monoclonal Antibody Based Products Market by Segment
in Japan: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Japan for the Years 2008 &
2012
Table 30: Monoclonal Antibody Based Products Market by Region
in Europe: 2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Region in Europe for the Years 2008 &
2012
Table 32: Monoclonal Antibody Based Products Market by Segment
in Europe: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Europe for the Years 2008 & 2012
Table 34: Monoclonal Antibody Based Products Market by Segment
in France: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in France for the Years 2008 & 2012
Table 36: Monoclonal Antibody Based Products Market by Segment
in Germany: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Germany for the Years 2008 &
2012
Table 38: Monoclonal Antibody Based Products Market by Segment
in Italy: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Italy for the Years 2008 &
2012
Table 40: Monoclonal Antibody Based Products Market by Segment
in the UK: 2007-2015 (Sales in US$ Million)
Table 41: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in the UK for the Years 2008 &
2012
Table 42: Monoclonal Antibody Based Products Market by Segment
in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Rest of Europe for the Years
2008 & 2012
Table 44: Monoclonal Antibody Based Products Market by Segment
in Rest of World: 2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Monoclonal Antibody Based
Products Market by Segment in Rest of World for the Years
2008 & 2012
COMPANIES PROFILED
To order this report:
Diagnostics Industry: Monoclonal Antibody Based Products - Global Trends
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article